Large body of evidence indicates that the combination of RAAS blockers with vitamin D and/or antioxidants might be useful to reduce RAAS activation and oxidative stress and prevent further cardiac and renal deterioration in CRS through detecting U-AGT and U-H2O2 [36, 86, 87]. Here, AGT is linked to congenital rubella syndrome.